-
-
-
-
-
-
-
Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $18 at Leerink Partners
-
-
-
-
-
-
-
Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
U.S. large biotech stocks Q2 earnings preview
-
-
-
-
-
-
-
Moderna (MRNA) Misses Q4 EPS by 18c; offers guidance
-
-
-
-
-
-
-
Argus Downgrades Moderna (MRNA) to Hold
-
-
-
-
-
-
-
Moderna stock: What could trigger a turnaround over the next 3-6 months?
-
1,197,288 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

